TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT01528930

Inhaled Amikacin Treatment for Nontuberculous Mycobacterial Lung Disease

Cause of deathSafety Automatic label, confidence 0.9, unverified. How labels are made.
“Although this study was approved at the Institutional Review Board, Korea Food \& Drug Administration (KFDA) did not approve this study due to safety concern.”

The sponsor’s own words in the registry.

Life of this trial

201220132014Registered2012-01-30Planned start2012-02 (planned)Withdrawn (as of)2012-12-17

Vital statistics

Status
Withdrawn
Phase
Phase 2
Sponsor
Samsung Medical Center
Sponsor type
University, hospital or other
Conditions
Pulmonary Non-tuberculous Mycobacterial Lung Disease
Interventions
Amikacin
Participants
0
Sites
1
Countries
South Korea

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.